TY - JOUR
T1 - Alkaloid fraction of jarong (achyranthes aspera linn) leaf induced apoptosis breast cancer cell through p53 pathways
AU - Adnyana, Dewa Putu Anom
AU - Meles, I. D.K.
AU - Meles, Wurlina
PY - 2012/1
Y1 - 2012/1
N2 - Achyranthesasperalinn leaf is used to treat cancer, particularly breast and cervix cancer. The alkaloid fraction of leaves Achyranthesasperalinn cause of death in accordance with the mechanism of myeloma cell apoptosis and necrosis associated with p53 gene and cycline dependent kinase 4.We employed mice with mammary cancer from benzo(α)pyeren induction to elucidate activity of leave extract of Achyranthesasperalinn to cure mammary cancer. The Mice with mammary cancer were divided into 5 groups there are group were treated with 0 mg/kg, 10 mg / kg, 30 mg / kg, and 100 mg / kg alkaloid Achyranthesaspera Linn by oraleveryday respectively; and group were treated with a standard anticancer drug cyclophosphamide 6 mg / kg for positive control. We also used healthy mice were treated with oilumolifarum as negative control. After 8 weeks treatment, mice were sacrificed to evaluate p53 and CDK expression level in mammary tissue. The results show that Achyranthesaspera Linn alkaloidsincreasedapoptosis in breast cancer cell through upregulate p53expression and inhibit CDK level in mammary cancer cells. Moreover, Achyranthesasperalinnin dose 10 mg/kgbw until 100 mg/kgbwshown have similar effect with Cyclophosamide 6 mg/kg bw.
AB - Achyranthesasperalinn leaf is used to treat cancer, particularly breast and cervix cancer. The alkaloid fraction of leaves Achyranthesasperalinn cause of death in accordance with the mechanism of myeloma cell apoptosis and necrosis associated with p53 gene and cycline dependent kinase 4.We employed mice with mammary cancer from benzo(α)pyeren induction to elucidate activity of leave extract of Achyranthesasperalinn to cure mammary cancer. The Mice with mammary cancer were divided into 5 groups there are group were treated with 0 mg/kg, 10 mg / kg, 30 mg / kg, and 100 mg / kg alkaloid Achyranthesaspera Linn by oraleveryday respectively; and group were treated with a standard anticancer drug cyclophosphamide 6 mg / kg for positive control. We also used healthy mice were treated with oilumolifarum as negative control. After 8 weeks treatment, mice were sacrificed to evaluate p53 and CDK expression level in mammary tissue. The results show that Achyranthesaspera Linn alkaloidsincreasedapoptosis in breast cancer cell through upregulate p53expression and inhibit CDK level in mammary cancer cells. Moreover, Achyranthesasperalinnin dose 10 mg/kgbw until 100 mg/kgbwshown have similar effect with Cyclophosamide 6 mg/kg bw.
KW - Achyranthesasperalinn
KW - Breast cancer
KW - Cycline dependent kinase
KW - P53 protein
UR - http://www.scopus.com/inward/record.url?scp=84860850705&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84860850705
SN - 1995-0772
VL - 6
SP - 124
EP - 127
JO - Advances in Natural and Applied Sciences
JF - Advances in Natural and Applied Sciences
IS - 2
ER -